Intellia Therapeutics Inc
NASDAQ:NTLA
Intellia Therapeutics Inc
NASDAQ:NTLA
Price:
13.67
USD
4.43%
Market Closed
Market Cap:
$1.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Intellia Therapeutics Inc
NASDAQ:NTLA
|
US |
|
Grand Canyon Education Inc
NASDAQ:LOPE
|
US |
|
Portillos Inc
NASDAQ:PTLO
|
US |
|
Aviva PLC
LSE:AV
|
UK |
|
M
|
Mondelez International Inc
SWB:KTF
|
US |
|
Qube Holdings Ltd
ASX:QUB
|
AU |
|
W
|
WW Grainger Inc
XMUN:GWW
|
US |
|
Aviva PLC
F:GU81
|
UK |
|
Denso Corp
TSE:6902
|
JP |
|
M
|
Moshi Moshi Retail Corporation PCL
SET:MOSHI
|
TH |
|
P
|
Park Dental Partners Inc
NASDAQ:PARK
|
US |
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
F
|
Ferrocarril del Pacifico SA
SGO:FEPASA
|
CL |
|
Gear4music (Holdings) PLC
F:G4A
|
UK |
|
F
|
Freeport-McMoRan Inc
BMV:FCX
|
US |
|
Minerals Technologies Inc
NYSE:MTX
|
US |
|
China Mobile Ltd
SSE:600941
|
CN |
|
US Bancorp
NYSE:USB
|
US |
Wall St Price Targets
NTLA Price Targets Summary
Intellia Therapeutics Inc
Intellia Therapeutics Inc
Wall Street analysts forecast NTLA stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for NTLA is 26.47 USD with a low forecast of 5.05 USD and a high forecast of 99.75 USD.
Lowest Forecast
Price Target
5.05
USD
63% Downside
Average Forecast
Price Target
26.47
USD
94% Upside
Highest Forecast
Price Target
99.75
USD
630% Upside
Intellia Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NTLA's stock price target?
Price Target
26.47
USD
26.47
USD
According to Wall Street analysts, the average 1-year price target for NTLA is 26.47 USD with a low forecast of 5.05 USD and a high forecast of 99.75 USD.
What is the Revenue forecast for Intellia Therapeutics Inc?
Projected CAGR
51%
51%
Over the last 10 years, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 8 years is 51%.
